7Baggers
 Rallybio completes first cohort dosing in RLYB116 C5 inhibitor study  Investing.com Thu, 25 Sep 2025 12:08:29 GMT
 rallybio corporation (nasdaq:rlyb) sees large drop in short interest  Defense World Sat, 20 Sep 2025 20:35:51 GMT
 published on: 2025-09-15 23:27:37  khodrobank.com Mon, 15 Sep 2025 20:00:38 GMT
 rallybio: $12.5 million equity milestone payment received  Pulse 2.0 Thu, 11 Sep 2025 15:57:26 GMT
 rallybio receives milestone payment as rev-10 advances  BioWorld MedTech Thu, 04 Sep 2025 13:00:00 GMT
 Rallybio receives $12.5M equity milestone payment  Hartford Business Journal Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 23:28:43  Newser Thu, 04 Sep 2025 04:28:43 GMT
 Rallybio Receives $12.5 Million Equity Milestone From Recursion  MarketScreener Wed, 03 Sep 2025 07:00:00 GMT
 mineralys’ strategic stock sale; gilead, shoreline partnership ends  Endpoints News Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-08-29 11:47:00  Newser Fri, 29 Aug 2025 16:47:00 GMT
 Rallybio Granted Extension for Nasdaq Compliance  TipRanks Fri, 29 Aug 2025 07:00:00 GMT
 published on: 2025-08-28 05:14:26  Newser Thu, 28 Aug 2025 10:14:26 GMT

Rallybio Corporation
(NASDAQ:RLYB) 

RLYB stock logo

Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead program is RLYB212, a preclinical-stage monoclonal anti-HPA-1a antibody for t...

Founded: 2018
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends